FDA Inspection 1288408 — KSL Biomedical, Inc.

KSL Biomedical, Inc. — FEI 3017505309

The FDA completed an inspection of KSL Biomedical, Inc. on October 24, 2025 in Buffalo, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 24, 2025
Fiscal Year
2026
Product Type
Devices
Project Area
Compliance: Devices
Location
Buffalo, NY (United States)

Citations

IDCFRDescription
1471521 CFR 820.30(d)Design output - Lack of or inadequate procedures
2280021 CFR 830.300(a)Devices subject to device identification GUDID data submission requirements.
326921 CFR 820.80(b)Incoming acceptance records, documentation